Congenital diaphragmatic eventration: Should we maintain surgical treatment? A retrospective multicentric cohort study.
Lymeymey Heng,Khalid Alzahrani,Louise Montalva,Guillaume Podevin,Françoise Schmitt,Naziha Khen-Dunlop,Nicoleta Panait,Erik Hervieux,Lucie Grynberg,Olivier Abbo,Frédéric Hameury,Frédéric Lavrand,Olivier Maillet,Aurore Haffreingue,Anne Lehn,Stephan De Napoli Cocci,Edouard Habonimana,Jean-Luc Michel,Louise Montalva,Quentin Ballouhey,Arnaud Fotso Kamdem,Jean-François Lecompte,Antoine Liné,Anna Poupalou,Pierre Maignan,Loren Deslandes
DOI: https://doi.org/10.1016/j.jpedsurg.2024.161991
IF: 2.549
2024-10-12
Journal of Pediatric Surgery
Abstract:Background The aims of this study were to describe the characteristics of children with congenital diaphragmatic eventration (CDE) and compare the outcomes of surgical and conservative treatment of pediatric CDE in France. Methods Retrospective study on cohort data conducted in 22 paediatric surgery departments, including patients less than 16 years of age diagnosed with CDE between 2010 and 2021. Patients with surgical or conservative treatment were compared. Results 139 patients were included, with a median age of 8 [1 – 16] months. CDE occurred in boys in 68.3% and was right-sided in 66.7% of the cases. Indication for treatment depended essentially on respiratory symptoms and level of the diaphragmatic dome. The initial treatment was a surgical, with a diaphragmatic plication, in 87 cases (62%) and conservative, consisting of clinical follow-up in 52 children (38%). Of the latter, 25 children underwent surgery secondarily. Intra- and early post-operative complications occurred in 32 children (29%) and eventration recurrence in 8 children (7%).With a median follow-up of 28 months, the median level of diaphragmatic dome improved from the 6th to the 9th back rib, and the rate of respiratory symptoms decreased from 64% to 14% in the overall cohort of patients. Conclusions Diaphragmatic plication is effective in symptomatic patients with a dome level above the 6 th posterior rib, but is associated with a 29% complication rate and 7% of recurrence.ClinicalTrials NCT04862494, April 28, 2021. Level of evidence level III treatment study.
pediatrics,surgery